Graf, S. A., Cassaday, R. D., Morris, K., Voutsinas, J. M., Wu, Q. V., Behnia, S., . . . Gopal, A. K. (2020). Ibrutinib monotherapy in relapsed or refractory, transformed diffuse large B-cell lymphoma. Clin Lymphoma Myeloma Leuk.
Citación estilo ChicagoGraf, Solomon A., et al. "Ibrutinib Monotherapy in Relapsed or Refractory, Transformed Diffuse Large B-cell Lymphoma." Clin Lymphoma Myeloma Leuk 2020.
Cita MLAGraf, Solomon A., et al. "Ibrutinib Monotherapy in Relapsed or Refractory, Transformed Diffuse Large B-cell Lymphoma." Clin Lymphoma Myeloma Leuk 2020.
Precaución: Estas citas no son 100% exactas.